NIKI NASDAQ
Niki BioSolutions, Inc.
1W: -3.4%
1M: -30.4%
3M: -42.6%
YTD: -42.6%
$4.60
-0.21 (-4.37%)
Weekly Expected Move ±13.0%
$3
$4
$5
$5
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.4M
52W Range4.52-259
Volume12,867
Avg Volume105,182
Beta0.17
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOChung Yuen Huen
Employees1
SectorHealthcare
IndustryBiotechnology
IPO Date2026-07-20
Websiteaptorumgroup.com
116 Village Boulevard, Suite 200
Princeton, NJ 08540
US
Princeton, NJ 08540
US
About Niki BioSolutions, Inc.
Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets. Its work spans from treatments for diseases with unmet medical needs, particularly in oncology and infectious diseases, to the development of innovative, blood-based diagnostic tests for brain health and other conditions.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Wu Justin Che Yuen | 0 | — | 2026-07-20 | |
| Arner Douglas Wayne | 0 | — | 2026-07-20 | |
| Mireskandari Alidad | 0 | — | 2026-07-20 | |
| Philips Laura A | 0 | — | 2026-07-20 | |
| Sheinerman Kira | 0 | — | 2026-07-20 |